BNP Paribas Financial Markets
PRAX icon

BNP Paribas Financial Markets’s Praxis Precision Medicines PRAX Stock Holding History

BNP Paribas Financial Markets’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$63.1M Buy
188,409
+45,327
+32% +$14.3M 0.02% 650
2026
Q1 		$46.1M Buy
143,082
+138,456
+2,993% +$42.8M 0.02% 721
2025
Q4 		$1.36M Buy
4,626
+241
+5% +$44.9K ﹤0.01% 2897
2025
Q3 		$232K Buy
4,385
+2,338
+114% +$113K ﹤0.01% 3937
2025
Q2 		$86.1K Sell
2,047
-5,404
-73% -$206K ﹤0.01% 4067
2025
Q1 		$282K Buy
7,451
+5,309
+248% +$332K ﹤0.01% 3519
2024
Q4 		$165K Sell
2,142
-7,383
-78% -$534K ﹤0.01% 3966
2024
Q3 		$548K Buy
9,525
+7,496
+369% +$405K ﹤0.01% 2820
2024
Q2 		$83.9K Sell
2,029
-4,721
-70% -$223K ﹤0.01% 3336
2024
Q1 		$412K Buy
+6,750
New +$303K ﹤0.01% 2954

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BNP Paribas Financial Markets's PRAX Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Praxis Precision Medicines (PRAX) stake by 32% in Q2 2026, buying an estimated $14.3M and bringing the position to 188,409 shares worth $63.1M. The position accounts for 0.02% of the portfolio, ranked #650.

BNP Paribas Financial Markets first reported a position in PRAX in Q1 2024 and has held it in 10 quarters since. 281 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • BNP Paribas Financial Markets held 188,409 shares of Praxis Precision Medicines worth $63.1M as of Q2 2026.
  • BNP Paribas Financial Markets bought 45,327 Praxis Precision Medicines shares in Q2 2026, an estimated $14.3M.
  • Praxis Precision Medicines made up 0.02% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #650 holding.
  • BNP Paribas Financial Markets first reported a position in Praxis Precision Medicines in Q1 2024 and has held it in 10 quarters since.
  • 281 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.